These findings are in accord with results of our study, thus indicating that LINC00261 is downregulated in several carcinomas and that its overexpression may play a very important role specifically in PC, thus highlighting LINC00261 as a potential molecular diagnostic marker for target for cancer therapy. Here, LINC00261 is linked to pachyonychia congenita.